Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BenQ Medical TechnologyROCO:4116 +0.76%86 EV-to-FCF is 11.62 as of Sep. 15, 2026, which is 2% above its 10-year median of 11.43. GuruFocus rates ROCO:4116 with a GF Score™ of 86/100 and a GF Value™ of NT$55.28 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 411 Medical Devices & Instruments companies, BenQ Medical Technology ranks better than 78.1% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, BenQ Medical Technology's Enterprise Value is NT$3,904 Mil.
BenQ Medical Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was NT$336 Mil. Therefore, BenQ Medical Technology's EV-to-FCF for today is 11.62.
The historical rank and industry rank for BenQ Medical Technology's EV-to-FCF or its related term are showing as below:
ROCO:4116'
s EV-to-FCF Range Over the Past 10 Years
Min: -1358.47 Med: 11.43 Max: 88.59
Current: 11.62
During the past 13 years, the highest EV-to-FCF of BenQ Medical Technology was 88.59. The lowest was -1358.47. And the median was 11.43.
ROCO:4116's EV-to-FCF is ranked better than 78.1% of 411
companies
in the Medical Devices & Instruments industry
Industry Median: 22.91
vs ROCO:4116: 11.62
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BenQ Medical Technology (ROCO:4116) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BenQ Medical Technology's PE Ratio (TTM) for today is calculated as:
BenQ Medical Technology's share price for today is NT$39.60.
BenQ Medical Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.622.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, BenQ Medical Technology's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BenQ Medical Technology EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BenQ Medical Technology's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where BenQ Medical Technology's EV-to-FCF falls into.
BenQ Medical Technology's current Enterprise Value is NT$3,904 Mil.
BenQ Medical Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$336 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BenQ Medical Technology (ROCO:4116) has a EV-to-FCF of 11.62 as of Sep. 15, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on BenQ Medical Technology and its competitors. This is near median its historical median of 11.43. According to the industry distribution chart, BenQ Medical Technology ranks #90 out of 411 companies in the Medical Devices & Instruments industry, placing it in the top 21.9%.
Is BenQ Medical Technology's EV-to-FCF too high?
BenQ Medical Technology's current EV-to-FCF of 11.62 is near median its 10-year median of 11.43. The Medical Devices & Instruments industry median EV-to-FCF is 22.91. BenQ Medical Technology's value of 11.62 is 49.3% below this industry median. Based on the distribution chart, BenQ Medical Technology ranks #90 out of 411 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, BenQ Medical Technology has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BenQ Medical Technology ranks #90 out of 411 companies for EV-to-FCF. This places BenQ Medical Technology in the top 22% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 22.91. BenQ Medical Technology's value of 11.62 is 49.3% below this benchmark. While the company's 10-year median is 11.43 vs. the industry median of 22.91, BenQ Medical Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.91, based on 411 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BenQ Medical Technology's current EV-to-FCF of 11.62 is 49.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on BenQ Medical Technology and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BenQ Medical Technology's current EV-to-FCF is 11.62, which is near median its own 10-year median of 11.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$55.28, compared to a current price of NT$39.60 — trading 28.4% below its estimated fair value. The current EV-to-FCF is 11.62, which is near median its 10-year median of 11.43 and 49.3% below the Medical Devices & Instruments industry median of 22.91. BenQ Medical Technology's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current EV-to-FCF is 11.62 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?
Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued.
The current stock price of NT$39.60 is trading 28.4% below its estimated GF Value™ of NT$55.28.
GuruFocus considers BenQ Medical Technology to be Modestly Undervalued.
Key valuation signals for ROCO:4116:
EV-to-FCF: 11.62 (near median its 10-year median of 11.43)
GF Value™: NT$55.28 vs. price of NT$39.60 (28.4% below fair value)
Industry Position: 49.3% below the Medical Devices & Instruments median (#90 of 411)
No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
86GF Score
Get the complete analysis for ROCO:4116
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4116 has been successfully added to your 
